Feng Li

19PUBLICATIONS

69CO-AUTHORS

Molecular targetsBiomaterialsGene and molecular therapyBiologically active moleculesPharmacogenomics

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (19)

Sort by Publication Date:

|Jun 27, 2026

Characterizing the Reactive Metabolites of Colony-Stimulating Factor 1 Receptor Inhibitor PLX5622 in Liver Microsomes and Mice.

|Dec 18, 2025

Metabolism, Pharmacokinetics, and Tissue Distribution of a Selective FK506-Binding Protein 12 F36V Mutant Degrader in Mice.

Shenzhi Zhou, Xuan Qin, Kevin Tran

|Jul 30, 2025

Low-dose metformin requires brain Rap1 for its antidiabetic action.

Hsiao-Yun Lin, Weisheng Lu, Yanlin He

|Nov 14, 2024

Discovery of highly potent and ALK2/ALK1 selective kinase inhibitors using DNA-encoded chemistry technology.

Ravikumar Jimmidi, Diana Monsivais, Hai Minh Ta

|Sep 28, 2024

CYP3A-Mediated Carbon-Carbon Bond Cleavages in Drug Metabolism.

Junhui Zhou, Xuan Qin, Shenzhi Zhou

|May 23, 2024

Reversible male contraception by targeted inhibition of serine/threonine kinase 33.

Angela F Ku, Kiran L Sharma, Hai Minh Ta

Pageof 4

Frequent Collaborators

Kiran L Sharma

Martin M Matzuk

Xuan Qin

Kurt M Bohren

Kevin R MacKenzie

Zhifeng Yu

Srinivas Chamakuri

Zian Liao

Jin Wang

Jeroen Pollet

Frequent Collaborators

Kiran L Sharma

Martin M Matzuk

Xuan Qin

Kurt M Bohren